Reconstitution of recombinant cytochrome P450 2C10(2C9) and comparison with cytochrome P450 3A4 and other forms: Effects of cytochrome P450-P450 and cytochrome P450-b(5) interactions

被引:120
|
作者
Yamazaki, H
Gillam, EMJ
Dong, MS
Johnson, WW
Guengerich, FP
Shimada, T
机构
[1] OSAKA PREFECTURAL INST PUBL HLTH,HIGASHINARI KU,OSAKA 537,JAPAN
[2] UNIV QUEENSLAND,DEPT PHYSIOL & PHARMACOL,ST LUCIA,QLD 4072,AUSTRALIA
[3] VANDERBILT UNIV,SCH MED,DEPT BIOCHEM,NASHVILLE,TN 37232
[4] VANDERBILT UNIV,SCH MED,CTR MOL TOXICOL,NASHVILLE,TN 37232
关键词
human P450; b(5); CYP2C10; CYP2C9; CYP3A4; CYP2E1; CYP2D6; CYP1A2; CYP1A1; reconstitution; xenobiotics; drug oxidation;
D O I
10.1006/abbi.1997.0125
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Tolbutamide methyl hydroxylation and S-warfarin 7-hydroxylation activities were reconstituted in systems containing recombinant human cytochrome P450 (P450 or CYP) 2C10(2C9) and the optimal conditions for the systems were compared with those of bufuralol 1'-hydroxylation by CYP1A1, theophylline 8-hydroxylation by CYP1A2, bufuralol 1'-hydroxylation by CYP2D6, chlorzoxazone 6-hydroxylation by CYP2E1, and testosterone 6 beta-hydroxylation by CYP3A4. CYP2C10 required cytochrome b(5) (b(5)) for optimal rates of tolbutamide and S-warfarin oxidations and b(5) could be replaced by apo-b(5); apo-b(5) and b(5) effects on the reconstituted systems have already been reported in systems containing CYP3A4 for the oxidation of testosterone and nifedipine and for the rapid reduction of CYP3A4 by NADPH-P450 reductase (H. Yamazaki et al., 1996, J. Biol. Chem. 271, 27438-27444). Stopped-flow studies, however, suggested that apo-b(5) as well as b(5) did not cause stimulation of the reduction of CYP2C10 by NADPH-P450 reductase, while the reduction rates were dependent on the substrates in reconstituted systems. Chlorzoxazone 6-hydroxylation by CYP2E1 was stimulated by b(5), but not by apo-b(5), in reconstituted systems. Neither apo- nor hole-b(5) increased bufuralol 1'-hydroxylation activity by CYP1A1 or 2D6 or theophylline 8-hydroxylation by CYP1A2. Interestingly, we found that testosterone 6 beta-hydroxylation by CYP3A4 was stimulated by CYP1A2 (and also by a modified form in which the first 36 residues of the native human protein were removed) and CYP1A1 as well as by b(5), and such stimulations were not seen when other P450 proteins (e.g., CYP2C10, 2D6, or 2E1) were added to the reconstituted systems. In contrast, substrate oxidations by CYP2C10 and CYP2E1 were not stimulated by other P450 proteins. The present results suggest that there are differences in optimal conditions for reconstitution of substrate oxidations by various forms of human P450 enzymes, and in some P45O-catalyzed reactions protein-protein interactions between P450 and b(5) and other P450 proteins are very important in some oxidations catalyzed by CYP2C10, 2E1, and 3A4. (C) 1997 Academic Press.
引用
收藏
页码:329 / 337
页数:9
相关论文
共 50 条
  • [21] Modeling complexes of substrates with cytochrome P450 2C9
    A. A. Pogrebnoi
    M. A. Grishina
    V. A. Potemkin
    D. A. Sysakov
    Pharmaceutical Chemistry Journal, 2010, 44 : 237 - 240
  • [22] Kinetics of electron transfer between NADPH-cytochrome P450 reductase and cytochrome P450 3A4
    Farooq, Yassar
    Roberts, Gordon C. K.
    BIOCHEMICAL JOURNAL, 2010, 432 : 485 - 493
  • [23] MODELING COMPLEXES OF SUBSTRATES WITH CYTOCHROME P450 2C9
    Pogrebnoi, A. A.
    Grishina, M. A.
    Potemkin, V. A.
    Sysakov, D. A.
    PHARMACEUTICAL CHEMISTRY JOURNAL, 2010, 44 (05) : 237 - 240
  • [24] Cytochrome P450 2C9 Is a Target for Photoreceptor Neuroprotection
    Chang, Qing
    Chen, Siquan
    Joseph, Bogaard
    Cao, Dingcai
    Grassi, Michael
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [25] Metabolism of steroids by cytochrome P450 2C9 variants
    Uno, Tomohide
    Nakano, Ryosuke
    Kitagawa, Risa
    Okada, Mai
    Kanamaru, Kengo
    Takenaka, Shinji
    Uno, Yuichi
    Imaishi, Hiromasa
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2018, 39 (08) : 371 - 377
  • [26] Interactions of cytochrome b(5) with recombinant human cytochrome P450 3A4 enhancement of catalysis
    Ueng, YF
    Johnson, WW
    Chun, YJ
    Yamazaki, H
    Shimada, T
    Martin, MV
    Guengerich, FP
    FASEB JOURNAL, 1996, 10 (06): : 2871 - 2871
  • [27] Human Cytochromes P450: Focus on Cytochrome P450 2C19
    Zvyaga, Tatyana
    Chang, Shu-Ying
    Chen, Cliff
    Yang, Zheng
    Vuppugalla, Ragini
    Hurley, Jeremy
    Thorndike, Denise
    Wagner, Andrew
    Chimalakonda, Anjaneya
    Rodrigues, A. David
    DRUG METABOLISM AND DISPOSITION, 2012, 40 (09) : 1698 - 1711
  • [28] Properties of cytochrome P450 isoenzymes and their substrates .2. properties of cytochrome P450 substrates
    Smith, DA
    Ackland, MJ
    Jones, BC
    DRUG DISCOVERY TODAY, 1997, 2 (11) : 479 - 486
  • [29] Cannabinoids and Cytochrome P450 Interactions
    Zendulka, Ondrej
    Dovrtelova, Gabriela
    Noskova, Kristyna
    Turjap, Miroslav
    Sulcova, Alexandra
    Hanus, Lumir
    Jurica, Jan
    CURRENT DRUG METABOLISM, 2016, 17 (03) : 206 - 226
  • [30] Interactions of herbs with cytochrome P450
    Zhou, SF
    Gao, YH
    Jiang, WQ
    Huang, M
    Xu, AL
    Paxton, JW
    DRUG METABOLISM REVIEWS, 2003, 35 (01) : 35 - 98